These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34528840)

  • 1. The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain.
    Chebini A; Marzoughi S; Randhawa J; Guh D; Wiseman S; Fedoroff I; Ong M
    Pain Manag; 2022 Apr; 12(3):337-346. PubMed ID: 34528840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subanesthetic, Subcutaneous Ketamine Infusion Therapy in the Treatment of Chronic Nonmalignant Pain.
    Zekry O; Gibson SB; Aggarwal A
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):91-8. PubMed ID: 27092576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of Subanesthetic Ketamine Bolus and Infusion for Opioid Refractory Cancer Pain.
    Forth N; Nguyen M; Grech A
    J Palliat Med; 2022 Jul; 25(7):1161-1165. PubMed ID: 35085456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Low-Dose Ketamine on the Usage of Continuous Opioid Infusion for the Treatment of Pain in Adult Mechanically Ventilated Patients in Surgical Intensive Care Units.
    Buchheit JL; Yeh DD; Eikermann M; Lin H
    J Intensive Care Med; 2019 Aug; 34(8):646-651. PubMed ID: 28468568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage.
    Onyebuchi CO; Chumpitazi CE; Placencia JL; Jackson AN; Jones JL; Torres L; Tubman VN
    J Pain Symptom Manage; 2024 Mar; 67(3):e169-e175. PubMed ID: 38000561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.
    Rakhman E; Shmain D; White I; Ekstein MP; Kollender Y; Chazan S; Dadia S; Bickels J; Amar E; Weinbroum AA
    Clin Ther; 2011 Jul; 33(7):863-73. PubMed ID: 21722959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Low-Dose Ketamine Infusion in Opioid Refractory Cancer Pain: A Case Report.
    Nath TS
    Cureus; 2022 Nov; 14(11):e31662. PubMed ID: 36545179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of ketamine infusion to dramatically reduce opioid requirements in a patient whose high-dose intrathecal opioid pump was inadvertently cut during surgery.
    McDonald WM; Wilkinson MM; Jain A; Cohen SP
    Pain Pract; 2023 Nov; 23(8):978-981. PubMed ID: 37312629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
    Elsewaisy O; Slon B; Monagle J
    Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ketamine in the therapy of chronic pain and depression].
    Jaksch W; Likar R; Aigner M
    Wien Med Wochenschr; 2019 Nov; 169(15-16):367-376. PubMed ID: 30980201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should Subanesthetic Ketamine be Considered When Managing Opioid Refractory Cancer Pain?
    Poon P; Bell RF; Good P
    J Pain Symptom Manage; 2024 Aug; 68(2):e146-e151. PubMed ID: 38729533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of 7- to 14-day subanesthetic ketamine infusions for chronic pain on standardized psychiatric measures.
    Marzoughi S; Ripsman D; Ong M
    Pain Manag; 2023 Sep; 13(9):529-538. PubMed ID: 37656045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study.
    Sheehy KA; Muller EA; Lippold C; Nouraie M; Finkel JC; Quezado ZM
    BMC Pediatr; 2015 Dec; 15():198. PubMed ID: 26620833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
    Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
    Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.
    Patil S; Anitescu M
    Pain Med; 2012 Feb; 13(2):263-9. PubMed ID: 21939497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subanesthetic ketamine infusions for the management of pediatric pain in non-critical care settings: An observational analysis.
    Masaracchia MM; Sites BD; Lee J; Thomas JJ; Fernandez PG
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1225-1230. PubMed ID: 31313291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged perioperative infusion of low-dose ketamine does not alter opioid use after pediatric scoliosis surgery.
    Pestieau SR; Finkel JC; Junqueira MM; Cheng Y; Lovejoy JF; Wang J; Quezado Z
    Paediatr Anaesth; 2014 Jun; 24(6):582-90. PubMed ID: 24809838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Orhurhu V; Orhurhu MS; Bhatia A; Cohen SP
    Anesth Analg; 2019 Jul; 129(1):241-254. PubMed ID: 31082965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.